Provided by Tiger Fintech (Singapore) Pte. Ltd.

Q32 Bio Inc.

2.00
+0.16008.70%
Post-market: 2.000.00000.00%16:05 EDT
Volume:121.08K
Turnover:237.01K
Market Cap:24.40M
PE:-0.30
High:2.01
Open:1.85
Low:1.85
Close:1.84
Loading ...

BRIEF-Q32 Bio Inc Restructuring Plan Includes Reduction In Force, Which Co Expects To Substantially Complete By End Of Q2 Of 2025

Reuters
·
11 Feb

BRIEF-Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve Resources

Reuters
·
11 Feb

Q32 Bio Inc: Expects to Incur Severance and Severance-Related Charges of About $1.1 Mln

THOMSON REUTERS
·
11 Feb

Q32 Bio Inc: Restructuring Plan Includes Reduction in Force, Which Co Expects to Substantially Complete by End of Q2 of 2025

THOMSON REUTERS
·
11 Feb

Q32 Bio Inc: Cash Runway Expected to Extend to 2H'26

THOMSON REUTERS
·
11 Feb

Q32 Bio Inc: Initiating Open-Label Extension From Signal-Aa Part a in 1H'25

THOMSON REUTERS
·
11 Feb

Q32 Bio Inc: Signal-Aa Part B Remains on Track for Initiation of Dosing in 1H'25, With Topline Data Expected in 1H'26

THOMSON REUTERS
·
11 Feb

Q32 Bio Inc: to Discontinue Renal Basket Trial for Adx-097 to Conserve Resources

THOMSON REUTERS
·
11 Feb

Q32 Bio Inc: Evaluate Strategic Options for Its Tissue-Targeted Complement Inhibitor Platform

THOMSON REUTERS
·
11 Feb

BUZZ-Guggenheim downgrades Q32 Bio to 'neutral' as dermatitis drug fails in part of study

Reuters
·
13 Dec 2024

Q32 Bio Inc Shares Hit Record Low After Guggenheim Downgrades Stock, Last Down 21.2%

THOMSON REUTERS
·
13 Dec 2024

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

Zacks
·
13 Dec 2024

Q32 Bio Cut to Neutral From Buy by Guggenheim

Dow Jones
·
12 Dec 2024

Q32 Bio Inc : Bmo Cuts Target Price to $22 From $64

THOMSON REUTERS
·
12 Dec 2024

Q32 Bio price target lowered to $20 from $80 at Oppenheimer

TipRanks
·
12 Dec 2024

Q32 Bio Inc : Guggenheim Cuts to Neutral

THOMSON REUTERS
·
12 Dec 2024